Some individuals develop a small area of redness or swelling at the injection site after IM administration
Most titration schedules start at 1-2mg for the first month, increase to 4mg for month two, then reach 8mg or 12mg by month three
however, the use will be subject to approval from the Research Ethics Board of the McGill University Health Centre
Individuals with immunocompromising health conditions, such as Type 2 Diabetes Mellitus (T2DM), have a weakened ability to control M
Wegovy is part of a class of drugs called GLP-1 Receptor Agonists that help people increase the amount of insulin in their body to lower the amount of sugar in their blood
Retatrutide could potentially tackle numerous obesity-related issues from cardiovascular to renal, positioning itself as a noteworthy contender in the upcoming metabolic disease arsenal